Inceptionr LLC Makes New Investment in Synopsys, Inc. $SNPS

Inceptionr LLC acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the first quarter, HoldingsChannel.com reports. The firm acquired 2,028 shares of the semiconductor company’s stock, valued at approximately $804,000.

Several other institutional investors have also modified their holdings of SNPS. Sankala Group LLC purchased a new position in shares of Synopsys in the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in Synopsys during the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys in the fourth quarter worth $28,000. Atlas Capital Advisors Inc. bought a new stake in Synopsys in the fourth quarter worth $32,000. Finally, Geneos Wealth Management Inc. boosted its stake in Synopsys by 151.5% during the first quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock worth $33,000 after buying an additional 50 shares during the period. 85.47% of the stock is owned by institutional investors.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Benchmark started coverage on shares of Synopsys in a research report on Wednesday, July 15th. They set a “buy” rating and a $570.00 price objective on the stock. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. Stifel Nicolaus upped their price target on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Wells Fargo & Company increased their price objective on shares of Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Finally, Citigroup boosted their target price on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Check Out Our Latest Stock Report on SNPS

Synopsys Stock Performance

Shares of Synopsys stock opened at $373.47 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The stock’s fifty day moving average price is $456.13 and its 200-day moving average price is $455.25. The firm has a market cap of $71.51 billion, a P/E ratio of 86.45, a P/E/G ratio of 2.19 and a beta of 1.22. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.